ValuatePad Companies Glossary

Income statement Cash flow Margins Balance sheet Market Shareholder returns Debt management JP Valuation DCF valuation EPV & WACC valuation Quality scores News and calendar Consensus and analysts

Income statement Cash flow Margins Balance sheet

Fundamentals of 500+ US-listed companies, as reported to the SEC. Free, no signup.

Explore

All companies
Financial glossary
About

The data

Methodology
Sources

© 2026 ValuatePad. Informational and educational content only. Not investment advice.

Novo Nordisk A/S

NVO

Forward P/E: 14.21×
Mkt cap: 214 B USD
EV: 229 B USD
Sector: Healthcare
Coverage: 2022–2025
Currency: USD · DKK
Next event: Mar 16, 2027

Consensus and analysts

Analyst consensus

Hold

37 analysts

Insiders (last month)

—

Analyst consensus

Hold · 37 analysts▲ +3 pts vs May 1, 2026

Strong buyBuyHoldSellStrong sell

Aug 1, 2026
37
Jul 1, 2026
37
Jun 1, 2026
37
May 1, 2026
37

Insider sentiment

No insider sentiment data for this ticker.